Healios KK
TSE:4593

Watchlist Manager
Healios KK Logo
Healios KK
TSE:4593
Watchlist
Price: 455 JPY 21.33% Market Closed
Market Cap: 46.2B JPY

Wall Street
Price Targets

Price Targets Summary
Healios KK

Wall Street analysts forecast Healios KK stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Healios KK is 391 JPY with a low forecast of 343.4 JPY and a high forecast of 441 JPY.

Lowest
Price Target
343.4 JPY
25% Downside
Average
Price Target
391 JPY
14% Downside
Highest
Price Target
441 JPY
3% Downside
Healios KK Competitors:
Price Targets
VCEL
Vericel Corp
56% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
44% Upside
RCKT
Rocket Pharmaceuticals Inc
1 455% Upside
2696
Shanghai Henlius Biotech Inc
23% Downside
LTRN
Lantern Pharma Inc.
636% Upside
CYTK
Cytokinetics Inc
153% Upside
MNKD
MannKind Corp
153% Upside
7774
Japan Tissue Engineering Co Ltd
109% Upside

Revenue
Forecast

Revenue Estimate
Healios KK

For the last 8 years the compound annual growth rate for Healios KK's revenue is 28%. The projected CAGR for the next 3 years is 105%.

28%
Past Growth
105%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Healios KK

Operating Income forecast
is not available for
Healios KK

Net Income
Forecast

Net Income Estimate
Healios KK

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Healios KK's stock price target?
Price Target
391 JPY

According to Wall Street analysts, the average 1-year price target for Healios KK is 391 JPY with a low forecast of 343.4 JPY and a high forecast of 441 JPY.

What is Healios KK's Revenue forecast?
Projected CAGR
105%

For the last 8 years the compound annual growth rate for Healios KK's revenue is 28%. The projected CAGR for the next 3 years is 105%.

Back to Top